Crohn's-like changes in the colon due to mycophenolate?

Colorectal Disease

Volumn 7, Issue 1, 2005, Pages 27-34

  Dalle, Ignace J ^a,b   Maes, B D ^a   Geboes, K P ^a   Lemahieu, W ^a   Geboes, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE   (Belgium)

Author keywords

Aetiology; Colon; Crohn; Diarrhoea; Histology; MMF; Mycophenolate

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DOXYCYCLINE; GANCICLOVIR; KI 67 ANTIGEN; METHYLPREDNISOLONE; METRONIDAZOLE; MUCIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; UVOMORULIN; VIBRATAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMPYLOBACTER; CHRONIC DIARRHEA; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLITIS; COLON BIOPSY; COLON DISEASE; COLON MUCOSA; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE EPITHELIUM; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CADHERINS; CASE-CONTROL STUDIES; CHRONIC DISEASE; COLON; DIARRHEA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; KI-67 ANTIGEN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 13844297527     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2004.00695.x     Document Type: Article

References (34)

1. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Yddney Transplant Study Group. Transplantation 1997; 63: 977-83.
2. Mayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997; 64: 436-43.
3. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 225-32.
4. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029-37.
5. Mathew TH. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Transplantation 1998; 65: 1450-4.
6. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-5.
7. Miller J, Mendez R, Pirsch JD, Jensik SC. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Transplantation 2000; 69: 875-80.
8. Squifflet JP, Backman L, Claesson K et al. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. Transplantation 2001; 72: 63-9.
9. Kreis H, Cisterne JM, Land W et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000; 69: 1252-60.
10. MacPhee IA, Spreafico S, Bewick M et al. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure. Kidney Int 2000; 57: 1164-8.
11. Wieland E, Shipkova M, Schellhaas U et al. Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects? Clin Biochem 2000; 33: 107-13.
12. Shipkova M, Wieland E, Schutz E et al. The acyl glucuronide metabolite of mycophenolic acid inhibits the proliferation of human mononuclear leukocytes. Transplant Proc 2001; 33: 1080-1.
13. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 1998; 34: 429-55.
14. Zeeh J, Inglin R, Baumann G et al. Mycophenolate mofetil impairs healing of left-sided colon anastomoses. Transplantation 2001; 71: 1429-35.
15. Fruhwirth M, Fischer H, Simma B, Ellemunter H. Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report. Pediatr Transplant 2001; 5: 132-4.
16. European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 1999; 68: 391-6.
17. Baert FJ, D'Haens GR, Peeters M et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly downregulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999; 116: 22-8.
18. Maes BD, Dalle I, Geboes K et al. Erosive enterocolitis in mycophenolate mofetil-treated renal- transplant recipients with persistent afebrile diarrhea. Transplantation 2003; 75: 665-72.
19. Ducloux D, Ottignon Y, Semhoun-Ducloux S et al. Mycophenolate mofetil-induced villous atrophy. Transplantation 1998; 66: 1115-6.
20. Golconda MS, Valente JF, Bejarano P, Gilinsky N, First MR. Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients. Transplant Proc 1999; 31: 272-3.
21. Tanaka M, Riddell RH, Saito H et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 1999; 34: 55-67.
22. Papadimitriou JC, Drachenberg CB, Beskow CO et al. Graft-versus-host disease-like features in mycophenolate mofetil-related colitis. Transplant Proc 2001; 33: 2237-8.
23. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants. J Pathol 2003; 201: 28-36.
24. Baer PC, Gauer S, Hauser IA, Scherberich JE, Geiger H. Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro. Nephrol Dial Transplant 2000; 15: 184-90.
25. Seitz S, Boelsterli UA. Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 1998; 115: 1476-82.
26. Maes BD, Lemahieu W, Kuypers D et al. Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. Am J Transplant 2002; 2: 989-92.
27. Hafez MM, Infante D, Winawer S, Friedman E. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Cell Growth Differ 1990; 1: 617-26.
28. Deng X, Bellis S, Yan Z, Friedman E. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Cell Growth Differ 1999; 10: 11-8.
29. van der Mast BJ, van Besouw NM, de Kuiper P et al. A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZA. Clin Transplant 2000; 14: 66-9.
30. Hueso M, Bover J, Seron D et al. Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with sub-optimal renal function. Transplantation 1998; 66: 1727-31.
31. Demetter P, De Vos M, Van Damme N et al. Focal upregulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. Am J Clin Pathol 2000; 114: 364-70.
32. Davidson MK, Russ PK, Glick GG et al. Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. Am J Ophthalmol 2000; 129: 267-9.
33. Russ PK, Davidson MK, Hoffman LH, Haselton FR. Partial characterization of the human retinal endothelial cell tight and adherens junction complexes. Invest Ophthalmol Vis Sci 1998; 39: 2479-85.
34. Miettinen PJ, Ebner R, Lopez AB, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127: 2021-36.